4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-24-052229
Chair and CEO sold 25,580 shares at an average $69.91 ($1,788,349)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $22.76 | $426,750 | 403,710 | D |
| 2024-12-19 | Sale : show line 2 in the form 10b5-1 | −13,162 | $69.65 | $916,733 | 390,548 | D |
| 2024-12-19 | Sale : show line 3 in the form 10b5-1 | −5,588 | $70.52 | $394,066 | 384,960 | D |
| 2024-12-19 | Exercise or conversion : show line 4 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2024-12-19 | Sale : show line 5 in the form 10b5-1 | −5,240 | $69.71 | $365,280 | 235,514 | I |
| 2024-12-19 | Sale : show line 6 in the form 10b5-1 | −1,590 | $70.61 | $112,270 | 233,924 | I |
| Open-market sales · 25,580 sh · avg $69.91 · $1,788,349 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-19 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −18,750 | 112,500 | D |
| 2024-12-19 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 232,290 | I |
Loading xslF345X05/wk-form4_1734729921.xml…